Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245 EUR | -0.08% | -2.62% | +15.68% |
05-16 | Swiss Market Index Rises; Roche Shines on Promising Weight-loss Drug | MT |
05-16 | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
Sales 2024 * | 60.06B 66.26B 60.96B 5,231B | Sales 2025 * | 63.61B 70.18B 64.57B 5,540B | Capitalization | 190B 209B 192B 16,508B |
---|---|---|---|---|---|
Net income 2024 * | 13.41B 14.8B 13.61B 1,168B | Net income 2025 * | 14.87B 16.4B 15.09B 1,295B | EV / Sales 2024 * | 3.38 x |
Net Debt 2024 * | 13.75B 15.17B 13.96B 1,198B | Net Debt 2025 * | 7.73B 8.53B 7.85B 673B | EV / Sales 2025 * | 3.1 x |
P/E ratio 2024 * |
13.7
x | P/E ratio 2025 * |
12.5
x | Employees | - |
Yield 2024 * |
4.14% | Yield 2025 * |
4.28% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -0.08% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 31/12/02 | |
Severin Schwan
CHM | Chairman | 57 | 31/12/07 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 31/03/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 02/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 31/12/95 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
+9.27% | 171B | |
+0.45% | 163B |
- Stock Market
- Equities
- ROG Stock
- RHO Stock